Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2020

01-08-2020 | Lymphoma | Case Report

Simultaneous macroamylasemia and macrolipasemia in a patient with mucosa-associated lymphoid tissue lymphoma

Authors: Nobuhiko Ogasawara, Tsunao Imamura, Yoshiki Sato, Tetsuo Tamura, Yuji Urasaki, Yuko Kono, Rikako Koyama, Naoko Inoshita, Aya Nishida

Published in: Clinical Journal of Gastroenterology | Issue 4/2020

Login to get access

Abstract

We report a case of simultaneous macroamylasemia and macrolipasemia complicated with mucosa-associated lymphoid tissue (MALT) lymphoma. A 78-year-old man presented with hyperamylasemia and hyperlipasemia for 2 years and was misdiagnosed with chronic pancreatitis at another hospital. However, his other pancreatic enzymes were normal, his amylase-creatinine clearance ratio was low, and no definite findings of pancreatic disease were evident. Immunological analyses revealed that both amylase and lipase were bound to immunoglobulin (Ig) A-κ, and that serum IgA was high (827.1 mg/dL). He was diagnosed with simultaneous macroamylasemia and macrolipasemia. Since these diseases are associated with malignancy, an additional investigation was performed which revealed the complication of MALT lymphoma, and polymerase chain reaction analysis showed monoclonal immunoglobulin light chain gene rearrangement (κ >> λ). In this case, macroamylasemia and macrolipasemia may have developed due to the formation of macroenzymes resulting from excess IgA-κ secreted by the MALT lymphoma. Simultaneous macroamylasemia and macrolipasemia are very rare and difficult to diagnose and can lead to diagnostic and therapeutic errors. When encountering atypical clinical features associated with hyperamylasemia and hyperlipasemia, the possibility of macroenzymes and underlying diseases such as lymphoproliferative disorders should be considered.
Literature
1.
go back to reference Forsman RW. Macroamylase: prevalence, distribution of age, sex, amylase activity, and electrophoretic mobility. Clin Biochem. 1986;19:250–3.CrossRef Forsman RW. Macroamylase: prevalence, distribution of age, sex, amylase activity, and electrophoretic mobility. Clin Biochem. 1986;19:250–3.CrossRef
2.
go back to reference Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection [review]. Clin Chem. 1989;35:2261–70.CrossRef Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection [review]. Clin Chem. 1989;35:2261–70.CrossRef
3.
go back to reference Zaman Z, Van Orshoven A, Mariën G, et al. Simultaneous macroamylasemia and macrolipasemia. Clin Chem. 1994;40:939–42.CrossRef Zaman Z, Van Orshoven A, Mariën G, et al. Simultaneous macroamylasemia and macrolipasemia. Clin Chem. 1994;40:939–42.CrossRef
4.
go back to reference Hameed AM, Lam VW, Pleass HC. Significant elevations of serum lipase not caused by pancreatitis: a systematic review. HPB (Oxford). 2015;17:99–112.CrossRef Hameed AM, Lam VW, Pleass HC. Significant elevations of serum lipase not caused by pancreatitis: a systematic review. HPB (Oxford). 2015;17:99–112.CrossRef
5.
go back to reference Taes YE, Louagie H, Yvergneaux JP. Prolonged hyperlipasemia attributable to a novel type of macrolipase. Clin Chem. 2000;46:2008–133.CrossRef Taes YE, Louagie H, Yvergneaux JP. Prolonged hyperlipasemia attributable to a novel type of macrolipase. Clin Chem. 2000;46:2008–133.CrossRef
6.
go back to reference Okumura Y, Tamba J, Shintani Y. Macrolipasemia in Crohn’s disease. Pancreas. 1998;16:205–10.CrossRef Okumura Y, Tamba J, Shintani Y. Macrolipasemia in Crohn’s disease. Pancreas. 1998;16:205–10.CrossRef
7.
go back to reference Keating JP, Lowe ME. Persistent hyperlipasemia caused by macrolipase in an adolescent. J Pediatr. 2002;141:129–31.CrossRef Keating JP, Lowe ME. Persistent hyperlipasemia caused by macrolipase in an adolescent. J Pediatr. 2002;141:129–31.CrossRef
8.
go back to reference Gullo L, Pezzilli R, Tomassetti P. Unusual association of macroamylasemia and hyperlipasemia: report of two cases. Am J Gastroenterol. 1996;91:2441–2.PubMed Gullo L, Pezzilli R, Tomassetti P. Unusual association of macroamylasemia and hyperlipasemia: report of two cases. Am J Gastroenterol. 1996;91:2441–2.PubMed
9.
go back to reference Yamashiro A, Oita T, Sakizono K, et al. Simultaneous presence of macroamylase and macrolipase in a patient. Rinsho Byori. 1997;45:391–4 (Japanese).PubMed Yamashiro A, Oita T, Sakizono K, et al. Simultaneous presence of macroamylase and macrolipase in a patient. Rinsho Byori. 1997;45:391–4 (Japanese).PubMed
10.
go back to reference Yuki T, Akagi S, Hirakawa K, et al. Simultaneous elevation of serum amylase and lipase levels due to multiclass immunoglobulin-bound enzymes in a patient with alcoholic liver cirrhosis. Pancreas. 1999;18:418–9.CrossRef Yuki T, Akagi S, Hirakawa K, et al. Simultaneous elevation of serum amylase and lipase levels due to multiclass immunoglobulin-bound enzymes in a patient with alcoholic liver cirrhosis. Pancreas. 1999;18:418–9.CrossRef
11.
go back to reference Goto H, Wakui H, Komatsuda A, et al. Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission. Intern Med. 2000;39:1115–8.CrossRef Goto H, Wakui H, Komatsuda A, et al. Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission. Intern Med. 2000;39:1115–8.CrossRef
12.
go back to reference Oita T, Yamashiro A, Mizutani F, et al. Simultaneous presence of macroamylase and macrolipase in a patient with celiac disease. Rinsho Byori. 2003;51:974–7 (Japanese).PubMed Oita T, Yamashiro A, Mizutani F, et al. Simultaneous presence of macroamylase and macrolipase in a patient with celiac disease. Rinsho Byori. 2003;51:974–7 (Japanese).PubMed
13.
go back to reference Kohse KP, Wisser H. Antibodies as a source of analytical errors. J Clin Chem Clin Biochem. 1990;28:881–92.PubMed Kohse KP, Wisser H. Antibodies as a source of analytical errors. J Clin Chem Clin Biochem. 1990;28:881–92.PubMed
14.
go back to reference Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program. 2005;1:307–13.CrossRef Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program. 2005;1:307–13.CrossRef
15.
go back to reference Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489–95.CrossRef Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489–95.CrossRef
16.
go back to reference Pudek MR, Jacobsen BE. Falsely negative laboratory diagnosis for myocardial infarction owing to the concurrent presence of macro creatine kinase and macro lactate dehydrogenase. Clin Chem. 1982;28:2434–7.CrossRef Pudek MR, Jacobsen BE. Falsely negative laboratory diagnosis for myocardial infarction owing to the concurrent presence of macro creatine kinase and macro lactate dehydrogenase. Clin Chem. 1982;28:2434–7.CrossRef
17.
18.
go back to reference Wu B, Chen P, Wang W, et al. IgA monoclonal gammopathy accompanying extranodal B cell lymphomas. Ann Hematol. 2014;93:521–2.CrossRef Wu B, Chen P, Wang W, et al. IgA monoclonal gammopathy accompanying extranodal B cell lymphomas. Ann Hematol. 2014;93:521–2.CrossRef
Metadata
Title
Simultaneous macroamylasemia and macrolipasemia in a patient with mucosa-associated lymphoid tissue lymphoma
Authors
Nobuhiko Ogasawara
Tsunao Imamura
Yoshiki Sato
Tetsuo Tamura
Yuji Urasaki
Yuko Kono
Rikako Koyama
Naoko Inoshita
Aya Nishida
Publication date
01-08-2020
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 4/2020
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01090-7

Other articles of this Issue 4/2020

Clinical Journal of Gastroenterology 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.